European Pharma 2023: A Rocky Year For Roche But Novo Is Rising Fast

Forecast For Europe’s Biggest Pharma Companies

 
• By Andrew McConaghie

Roche remains the European sector’s biggest company despite a wobble in 2022, but Novo Nordisk’s spectacular growth has seen it overtake AstraZeneca and Novartis in market cap terms.

Novo Nordisk
Novo Nordisk is expected to be the standout performer in European pharma in 2023 thanks to its rapidly growing diabetes and obesity franchise. • Source: Shutterstock

More from Anticancer

More from Therapy Areas